UroGen Pharma Ltd (URGN) — Capital Reinvestment Ratio
UroGen Pharma Ltd (URGN) has a Capital Reinvestment Ratio of 0.01x as of September 2017, meaning it reinvests 0% of its operating cash flow ($2.60 Million) in capital expenditures ($20.00K). See URGN net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
UroGen Pharma Ltd Capital Reinvestment Ratio (2016–2016)
This chart tracks UroGen Pharma Ltd's Capital Reinvestment Ratio across 1 annual periods. Check UroGen Pharma Ltd (URGN) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for UroGen Pharma Ltd (2016–2016)
Year-by-year Capital Reinvestment Ratio for UroGen Pharma Ltd from 2016 to 2016. For live market cap and broader valuation context, see how much is UroGen Pharma Ltd worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.17x | $4.19 Million | $695.00K | — |